Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAT3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | GTF2E1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | IFT20 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | CLN3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | PDHB | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | MBD1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | TAS2R31 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | DEFB105B | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | ZNF2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | CYP19A1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |